Back to the search results

St. Agnes-Hospital Bocholt

St. Agnes-Hospital Bocholt
St. Agnes-Hospital Bocholt

Barloer Weg 125
46397 Bocholt

Phone: 02871-200
Fax: 02871-202804
Mail: ed.lmwk@ofni

  • Number of beds: 461
  • Number of specialist departments: 13
  • Number of inpatient cases: 18.896
  • Number of partial inpatient cases: 25
  • Number of outpatient cases: 52.779
  • Hospital owners: Klinikum Westmünsterland GmbH
  • Type of provider: freigemeinnützig
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Quantity performed 100
Exception? No exception
Quantity performed 32
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 100
Quantity forecast year: 106
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 32
Quantity forecast year: 27
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 177
Quantity forecast year: 183
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ30 Quality assurance guideline for interstitial LDR brachytherapy for low-risk localized prostate cancer (effective January 8, 2021).
CQ07 Measures for quality assurance in the care of pre-term and full-term neonates – perinatal focus
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: yes
Number Group
124 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
19 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
15 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Name of the working group: LSR - Lenkungsgremium Sicherheitskultur und Risikomanagement

Leitfaden Arzneimittelanamnese

01.10.2021

Teil der QM/RM Dokumentation

31.12.2021

  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • Web Muse
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Klinik für Urologie (PD Dr. Oberpenning): Lehre (Uni Münster); Klinik für Allgemein-, Viszeral- und Tumorchirurgie (CA Dr. Überrück): Lehre Uni Essen und Uni Jena

Explanation

Im Rahmen des Onkologischen Zentrums, des Brust-, Darm-, und Gynäkologischen Krebszentrums, z.B. PanaMa Studie; Zusätzlich Teilnahme an Evaluations- und Beobachtungsstudien, bspw. Klinik für Urologie: OnkoTrakt Studie, PRIAS Studie, EvEnt-PCA-Studie und Alice-Studie

Explanation

Im Rahmen des Onkologischen Zentrums, des Brust-, Darm- und Gynäkologischen Krebszentrums Teilnahme an multizentrischen Phase-III/IV Studien, z.B. Hyposib Studie, Klinik für Kinder- und Jugendmedizin nimmt an multizentrischen Studien und an Anwendungsbeobachtungen teil z.B. Harmonie-Studie, COACH-S

Explanation

Klinik für Unfallchirurgie (Dr. Hinkenjann), Klinik für Urologie (Dr. Oberpenning), Klinik für Radiologie (Dr. Hilje)

Explanation

Sommercamp für Studierende der Medizin; Radiologie: Zusammenarbeit mit der Universität Paderborn – Analytic Information Systems and Buisiness Intelligence Klinik für Allgemein- Viszeral- und Tumorchirurgie: Famulaturen

Explanation

Forschung im Bereich der Schulterendoprothetik mit der Uni Essen

Training in other healing professions
Comment

Comment

Die Praxiseinsätze der Ausbildung finden unter anderem am St. Agnes-Hospital statt (Schule in Kleve)

Comment

Comment

Berufspraktische Ausbildung findet im St. Agnes-Hospital Bocholt statt. Fachpraktische Ausbildung mit der Medical School academia chirurgica in Düsseldorf

Comment

Comment

Die Praxiseinsätze der Ausbildung finden unter anderem am St. Agnes-Hospital statt.

Comment

Comment

Comment

Berufspraktische Ausbildung findet im St. Agnes-Hospital Bocholt statt. Fachpraktische Ausbildung mit der Medical School academia chirurgica in Düsseldorf

Prof. Dr. med. Jobst Nitsch

Patientenfürsprecher

Barloer Weg 125
46397 Bocholt

Phone: 0160 -4791765-
Mail: ed.tlohcob-senga-ts@rehcerpsreufnetneitap

Rosanna Bachmann

Sekretariat der Geschäftsführung

Barloer Weg 125
46397 Bocholt

Phone: 02871 -20-2047
Mail: ed.lmwk@tlohcob-gnurheufstfeahcseg

Rosanna Bachmann

Sekretariat der Geschäftsführung

Barloer Weg 125
46397 Bocholt

Phone: 02871 -20-2047
Mail: ed.lmwk@tlohcob-gnurheufstfeahcseg

Dipl. Pflegewirtin Anne Panzer

Teamleitung des Allg. QM an den Standorten Borken, Bocholt und Rhede

Barloer Weg 125
46397 Bocholt

Phone: 02871 -20-2544
Mail: ed.lmwk@reznap.enna

Dr. med Olaf Baumhove

Ärztlicher Direktor

Barloer Weg 125
46397 Bocholt

Phone: 02871 -20-2993
Mail: ed.tlohcob-senga-ts@eisehtseana

Dipl. Pflegemanager Ingo Jansen

Pflegedirektor

Barloer Weg 125
46397 Bocholt

Phone: 02871 -20-2570
Mail: ed.tlohcob-senga-ts@noitkeridegelfp

Dipl. Pflegemanager Ingo Jansen

Pflegedirektor

Barloer Weg 125
46397 Bocholt

Phone: 02871 -20-2570
Mail: ed.tlohcob-senga-ts@noitkeridegelfp

Barloer Weg 125
46397 Bocholt

Phone: 02871-200
Fax: 02871-202804
Mail: ed.lmwk@ofni

MAS Health Service Management, MSc IT im Gesundheitswesen Ingo Jansen

Pflegedirektor

Barloer Weg 125
46397 Bocholt

Phone: 02871 -20-2570
Mail: ed.tlohcob-senga-ts@noitkeridegelfp

MAS Health Service Management, MSc IT im Gesundheitswesen Ingo Jansen

Pflegedirektor

Barloer Weg 125
46397 Bocholt

Phone: 02871 -20-2570
Mail: ed.tlohcob-senga-ts@noitkeridegelfp

Dipl. Krankenhausbetriebswirt (VKD) Herbert Mäteling

Geschäftsführer

Barloer Weg 125
46397 Bocholt

Phone: 02871 -20-2045
Mail: ed.lmwk@lekniwsalf.etaner

Dipl. Krankenhausbetriebswirt (VKD) Herbert Mäteling

Geschäftsführer

Barloer Weg 125
46397 Bocholt

Phone: 02871 -20-2045
Mail: ed.lmwk@lekniwsalf.etaner

Dr. med. Olaf Baumhove

Ärztlicher Direktor

Barloer Weg 125
46397 Bocholt

Phone: 02871 -20-2993
Mail: ed.tlohcob-senga-ts@eisehtseana

IK: 260550277

More IK: 260550266

Location number: 771286000

Old location number: 771286000